| Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium JR Lurain, BL Rice, AW Rademaker, LE Poggensee, JC Schink, DS Miller Obstetrics & Gynecology 78 (1), 63-69, 1991 | 275 | 1991 |
| Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53 JT Soper, DG Mutch, JC Schink, ... Gynecologic oncology 93 (3), 575-585, 2004 | 255 | 2004 |
| Tumor size in endometrial cancer JC Schink, DS Miller, JR Lurain, AW Rademaker Cancer 67 (11), 2791-2794, 1991 | 247 | 1991 |
| Bringing PROMIS to practice: brief and precise symptom screening in ambulatory cancer care LI Wagner, J Schink, M Bass, S Patel, MV Diaz, N Rothrock, T Pearman, ... Cancer 121 (6), 927-934, 2015 | 218 | 2015 |
| Phase I Study of Continuous-Infusion l - S,R -Buthionine Sulfoximine With Intravenous Melphalan HH Bailey, G Ripple, KD Tutsch, RZ Arzoomanian, D Alberti, ... Journal of the National Cancer Institute 89 (23), 1789-1796, 1997 | 203 | 1997 |
| Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary … GS De Oliveira, S Ahmad, JC Schink, DK Singh, PC Fitzgerald, ... Regional Anesthesia & Pain Medicine 36 (3), 271-277-271-277, 2011 | 190 | 2011 |
| Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study RJ Osborne, V Filiaci, JC Schink, RS Mannel, A Alvarez Secord, JL Kelley, ... Journal of Clinical Oncology 29 (7), 825-831, 2011 | 180 | 2011 |
| Ovarian cancer, version 2.2013 RJ Morgan, RD Alvarez, DK Armstrong, RA Burger, L Chen, L Copeland, ... Journal of the National Comprehensive Cancer Network 11 (10), 1199-1209, 2013 | 155 | 2013 |
| 15 years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage J Brown, RW Naumann, MJ Seckl, J Schink Gynecologic oncology 144 (1), 200-207, 2017 | 153 | 2017 |
| Tumor size in endometrial cancer: a prognostic factor for lymph node metastasis JC Schink, JR Lurain, CB Wallemark, JS Chmiel Obstetrics & Gynecology 70 (2), 216-219, 1987 | 153 | 1987 |
| A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer AM Westermann, EA Grosen, DM Katschinski, D Jäger, R Rietbroek, ... European journal of cancer 37 (9), 1111-1117, 2001 | 146 | 2001 |
| High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence—the University of Wisconsin experience DG Petereit, JN Sarkaria, DM Potter, JC Schink International Journal of Radiation Oncology* Biology* Physics 45 (5), 1267-1274, 1999 | 142 | 1999 |
| Epithelial ovarian cancer RJ Morgan, RD Alvarez, DK Armstrong, B Boston, RA Burger, L Chen, ... Journal of the National Comprehensive Cancer Network 9 (1), 82-113, 2011 | 134 | 2011 |
| Role of surgery in the management of high-risk gestational trophoblastic neoplasia JR Lurain, DK Singh, JC Schink JOURNAL OF REPRODUCTIVE MEDICINE-CHICAGO- 51 (10), 773, 2006 | 123 | 2006 |
| Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy. JR Lurain, DK Singh, JC Schink The Journal of reproductive medicine 51 (10), 767-772, 2006 | 110 | 2006 |
| Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors LE Weinberg, JR Lurain, DK Singh, JC Schink Gynecologic oncology 121 (2), 285-289, 2011 | 107 | 2011 |
| Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy E Chapman-Davis, AV Hoekstra, AW Rademaker, JC Schink, JR Lurain Gynecologic oncology 125 (3), 572-575, 2012 | 106 | 2012 |
| Barriers to prevention: knowledge of HPV, cervical cancer, and HPV vaccinations among African American women AE Strohl, G Mendoza, MS Ghant, KA Cameron, MA Simon, JC Schink, ... American journal of obstetrics and gynecology 212 (1), 65. e1-65. e5, 2015 | 105 | 2015 |
| Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group J Brown, WE Brady, J Schink, L Van Le, M Leitao, SD Yamada, ... Cancer 120 (3), 344-351, 2014 | 98 | 2014 |
| Malignant melanoma of the vulva: an extension of cutaneous melanoma? KM Moxley, AN Fader, PG Rose, AS Case, DG Mutch, E Berry, JC Schink, ... Gynecologic oncology 122 (3), 612-617, 2011 | 95 | 2011 |
